Stride Shasun Receives 'Zero' 483 Observations, Stock Up


Pharma major, Stride Shasun received zero 483 observations in the US Food and Drug Administration’s (USFDA) routine GMP inspection of its oral dosage facility in Puducherry on May 2, 2017. 

Followed by the declaration of the observation, the share price of Stride Shasun opened at Rs 1089 at 9:15 am on the BSE. At 10:10 hrs IST on May 2, 2017, Strides Shasun was trading at Rs 1,080.65, up Rs 7.75, or 0.75 per cent on the BSE.

The stock touched its 52-week high trading at Rs 1,259 and 52-week low at Rs 952.50 on 03 February 2017 and 29 August 2016, respectively. Recently, the drug maker company’s Cuddalore facility had also cleared a USFDA inspection successfully. 

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717 
Share on Google Plus Share on Pinterest

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: